I am very grateful for the exceptional care I received at Sunstone Therapies. The team’s profound experience and genuine compassion created an environment where I felt fully supported and secure at every stage of the process.
Psilocybin Study Participant
Recent Posts
At Sunstone, safety and comfort extend far beyond the dosing room. Discover how our comprehensive care model protects both physical and psychological well-being through rigorous clinical evaluations, ongoing consent discussions, and dedicated post-dosing integration support.
Trauma-informed care (TIC) is essential to minimizing risks and maximizing growth during psychedelic therapy. Explore Sunstone’s patient-centered framework, where continuous informed consent, psychological safety, and individualized care are built into every step of the treatment process.
Sunstone Therapies is enrolling for SUN004, a Phase 2 study of psilocybin therapy for women with sexual assault-related PTSD. This trauma-informed trial utilizes a Shared Decision-Making framework to prioritize survivor agency and trust. Learn about our patient-led approach, which includes preparatory sessions, specialized therapeutic support, and optional long-term group integration.